Skip to main content
Skip to main content
JACS-RI logo

Jackson Acquisition Company II (JACS-RI) Stock Analysis

$0.088 +$0.00 (+0.00%) |CouncilSplit View · 48 · C
Jackson Acquisition Company II (JACS-RI) bottom line: Split View — our Council read (48/100) and AI Score (46/100) broadly agree. Strongest signal: Izzy Englander bullish · Biggest watch-out: Moon AI bearish.
MCap: $2.10M| Vol: 1.1K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Jackson Acquisition Company II (JACS-RI) trades at $0.088 with AI Score 46/100 (Grade C). Jackson Acquisition Company II is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare… Market cap: $2.10M, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: May 9, 2026
Jackson Acquisition Company II is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare or consumer sectors. The company aims to leverage its management team's expertise to create value through a public listing.

Analyst Coverage for JACS-RI: JACS-RI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JACS-RI against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the JACS-RI film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 48/100 · C

JACS-RI: the 3 scored disciplines are evenly split. Dominant signal: Izzy Englander bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bearish
Moon AI
Bearish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Jackson Acquisition Company II (JACS-RI) Financial Services Profile

HeadquartersGA, US
IPO Year2025

Jackson Acquisition Company II is a special purpose acquisition company (SPAC) targeting businesses within the healthcare and consumer sectors. The company seeks to identify and acquire a company with a proven business model, strong competitive positioning, and significant opportunities for value creation through a public listing, leveraging its management's operational expertise.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 9, 2026

What Is the Investment Thesis for JACS-RI?

As of May 9, 2026 — figures reflect the data available on that date.

Jackson Acquisition Company II presents an investment opportunity predicated on the successful identification and acquisition of a target company with strong growth potential. The company's management team's experience in the healthcare and consumer sectors suggests a focused approach to finding a suitable merger candidate. The key value driver lies in the ability to identify a company with a proven business model and a clear path to increased profitability and market share post-acquisition. However, the success of this investment hinges on the management team's ability to navigate the competitive landscape of SPAC acquisitions and secure a deal that delivers long-term value to shareholders. The current P/E ratio of 0.38 indicates potential undervaluation, but this metric should be interpreted cautiously given the nature of SPACs and the absence of an operating business.

Based on FMP financials and quantitative analysis

JACS-RI Key Highlights

Jackson Acquisition Company II operates as a special purpose acquisition company (SPAC) targeting the healthcare and consumer sectors.

  • The company's objective is to identify and acquire a business with a proven model and strong competitive position.
  • The management team brings experience in the healthcare and consumer sectors, guiding the company's acquisition strategy.
  • The company's P/E ratio is 0.38 as of 2026-05-09, reflecting its status as a SPAC without current operations.
  • Jackson Acquisition Company II aims to create value through a successful merger and subsequent growth of the acquired company.

Who Are JACS-RI's Competitors?

JACS-RI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ALISR Calisa Acquisition Corp Right $0.64 +0.00% 79
IDKFF ThreeD Capital Inc. $0.07 +13.85% $6.98M 70
ALTEX Firsthand Alternative Energy Fund $12.93 -1.90% $8.98M 82
BCG Binah Capital Group, Inc. $1.40 +0.72% $23.5M 78
EEA The European Equity Fund, Inc. $11.15 -0.59% $74.7M 67
HNNA Hennessy Advisors, Inc. $9.89 -1.30% $78.2M 81
ETHT ProShares - Ultra Ether ETF $12.57 +19.94% $92.2M 68
TPZ Tortoise Electrification Infrastructure ETF $21.62 -0.18% $127M 70

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are JACS-RI's Key Strengths?

Experienced management team with expertise in the healthcare and consumer sectors.

  • SPAC structure provides a pathway for private companies to become publicly listed.
  • Access to capital through its initial public offering and subsequent fundraising efforts.
  • Focus on identifying and acquiring companies with strong growth potential.

What Are JACS-RI's Weaknesses?

Dependence on identifying and acquiring a suitable target company.

  • Competition from other SPACs seeking attractive acquisition targets.
  • Uncertainty regarding the future performance of the acquired company.
  • Potential for conflicts of interest between management and shareholders.

What Could Drive JACS-RI Stock Higher?

Announcement of a definitive agreement to acquire a target company.

  • Progress in the due diligence process for potential acquisition targets.
  • Successful integration of the acquired company into Jackson Acquisition Company II's operations.

What Are the Key Risks for JACS-RI?

Failure to identify and acquire a suitable target company within the specified timeframe.

  • Increased competition from other SPACs seeking attractive acquisition targets.
  • Economic downturn or recession impacting the performance of the acquired company.
  • Changes in government regulations affecting the healthcare or consumer sectors.

What Are the Growth Opportunities for JACS-RI?

  • Successful Acquisition of a High-Growth Target: Jackson Acquisition Company II's primary growth opportunity lies in identifying and acquiring a company with significant growth potential within the healthcare or consumer sectors. The success of the acquisition will depend on the target company's existing market position, growth trajectory, and the ability of the combined entity to execute its business plan effectively. The timeline for realizing this growth opportunity is dependent on the speed and efficiency of the acquisition process, with potential for value creation within 1-3 years post-acquisition.
  • Leveraging Management Expertise: The management team's experience in the healthcare and consumer sectors provides a competitive advantage in identifying and evaluating potential acquisition targets. Their expertise can help in assessing the target company's business model, competitive landscape, and growth opportunities, increasing the likelihood of a successful acquisition. This expertise can also be leveraged to provide operational and strategic guidance to the acquired company, accelerating its growth and value creation.
  • Capitalizing on Market Trends: Jackson Acquisition Company II can capitalize on emerging trends in the healthcare and consumer sectors to identify attractive acquisition targets. For example, the company could focus on businesses that are benefiting from the increasing adoption of digital health technologies or the growing demand for sustainable consumer products. By aligning its acquisition strategy with these trends, Jackson Acquisition Company II can increase its chances of finding a high-growth target with long-term potential.
  • Improving Operational Efficiency Post-Acquisition: Following the acquisition of a target company, Jackson Acquisition Company II can focus on improving its operational efficiency to drive profitability and value creation. This could involve streamlining processes, reducing costs, and implementing new technologies to enhance productivity. By improving operational efficiency, the company can increase its margins and generate higher returns for its shareholders. The timeline for realizing these improvements is typically within 1-2 years post-acquisition.
  • Expanding into New Markets: The acquired company may have opportunities to expand into new geographic markets or customer segments, driving further growth and value creation. Jackson Acquisition Company II can support this expansion by providing capital, expertise, and access to its network of contacts. By expanding into new markets, the company can diversify its revenue streams and reduce its reliance on any single market or customer segment. The timeline for realizing this expansion is dependent on the specific opportunities available to the acquired company, but typically within 2-3 years post-acquisition.

What Are JACS-RI's Competitive Advantages?

  • Management Team Expertise: The management team's experience in the healthcare and consumer sectors provides a competitive advantage in identifying and evaluating potential acquisition targets.
  • SPAC Structure: The SPAC structure provides a pathway for private companies to become publicly listed without undergoing the traditional IPO process, making Jackson Acquisition Company II an attractive partner for potential acquisition targets.
  • Access to Capital: Jackson Acquisition Company II has access to capital through its initial public offering and subsequent fundraising efforts, allowing it to finance acquisitions and support the growth of acquired companies.

What Does JACS-RI Do?

Jackson Acquisition Company II is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed with the sole purpose of identifying, acquiring, and operating a business that can benefit from the management team's operational expertise and strategic network. The company's leadership brings experience in the healthcare and consumer sectors, indicating a potential focus for acquisition targets within these industries. Jackson Acquisition Company II is designed to provide a pathway for private companies to become publicly listed without undergoing the traditional initial public offering (IPO) process. The company seeks to partner with a business that has demonstrated a proven business model, a robust competitive position within its market, and substantial opportunities for value creation and growth following its transition to a publicly traded entity. By leveraging the SPAC structure, Jackson Acquisition Company II aims to deliver value to its shareholders through the successful identification, acquisition, and operation of a high-potential target company.

What Products and Services Does JACS-RI Offer?

  • Identifies potential acquisition targets within the healthcare and consumer sectors.
  • Evaluates the business model, competitive position, and growth opportunities of target companies.
  • Negotiates and structures acquisition agreements.
  • Raises capital to finance acquisitions.
  • Provides operational and strategic guidance to acquired companies.
  • Creates value for shareholders through successful acquisitions and subsequent growth of acquired companies.

How Does JACS-RI Make Money?

  • Jackson Acquisition Company II generates revenue through the successful acquisition and subsequent growth of a target company.
  • The company's management team receives compensation for their services, typically in the form of equity and fees.
  • The company aims to create value for its shareholders through the appreciation of its stock price following a successful acquisition.

What Industry Does JACS-RI Operate In?

Jackson Acquisition Company II operates within the financial services sector, specifically as a special purpose acquisition company (SPAC). The SPAC market has seen significant growth in recent years, offering an alternative route for companies to go public compared to traditional IPOs. However, the industry is also characterized by intense competition among SPACs seeking attractive acquisition targets. The success of Jackson Acquisition Company II depends on its ability to differentiate itself and secure a deal that delivers value to its shareholders in a competitive market.

Who Are JACS-RI's Key Customers?

  • Jackson Acquisition Company II's primary customers are its shareholders, who invest in the company with the expectation of generating returns through successful acquisitions.
  • Potential acquisition targets are also considered customers, as Jackson Acquisition Company II provides them with a pathway to becoming publicly listed.
  • The company also serves the broader financial community, including investment banks, legal advisors, and other service providers involved in the acquisition process.
AI Confidence: 64% Updated: May 9, 2026

How Jackson Acquisition Company II Is Valued

Jackson Acquisition Company II carries a market capitalization of $2.10M, placing it in the micro-cap category. Relative to its peer group, JACS-RI's quantitative score of 46/100 is below the peer average of 75/100.

Company Profile

Jackson Acquisition Company II operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Alpharetta, US. The company is led by CEO Richard L. Jackson. JACS-RI has traded publicly since 2025.

ROE 3%

Key Financial Metrics

Return on equity for Jackson Acquisition Company II stands at 3.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.4%, showing how much profit it generates from its asset base. JACS-RI trades at a trailing price-to-earnings ratio of 29.02, above the Financial Services sector average of ~18x. Its free cash flow yield is -0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.77 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.4%, the inverse of the P/E and a quick read on earnings relative to price.

JACS-RI Financials

Bull Case vs Bear Case

Bull Case

  • Experienced management team with expertise in the healthcare and consumer sectors.
  • SPAC structure provides a pathway for private companies to become publicly listed.
  • Access to capital through its initial public offering and subsequent fundraising efforts.
  • Focus on identifying and acquiring companies with strong growth potential.

Bear Case

  • Dependence on identifying and acquiring a suitable target company.
  • Competition from other SPACs seeking attractive acquisition targets.
  • Uncertainty regarding the future performance of the acquired company.
  • Potential for conflicts of interest between management and shareholders.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

JACS-RI Latest News

No recent news available for JACS-RI.

JACS-RI Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for JACS-RI.

Price Targets

Wall Street price target analysis for JACS-RI.

JACS-RI MoonshotScore

46/100

What does this score mean?

The MoonshotScore rates JACS-RI 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Jackson Acquisition Company II Financial Services Stock: Key Questions Answered

What does the AI Score mean for JACS-RI?

JACS-RI holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Jackson Acquisition Company II is a special purpose acquisition company (SPAC) focused on merging with a business in the healthcare or consumer sectors. The company aims to leverage its management …

What does Jackson Acquisition Company II do?

Jackson Acquisition Company II is a special purpose acquisition company (SPAC) that aims to identify and acquire a private company, primarily in the healthcare or consumer sectors, to bring it public.

What do analysts say about JACS-RI stock?

As of 2026-05-09, there is limited analyst coverage specifically for Jackson Acquisition Company II (JACS-RI) due to its nature as a SPAC. However, the company's P/E ratio of 0.38 may indicate potential undervaluation. Investors should closely monitor the company's progress in identifying and acquiring a target company, as this will be the primary driver of its future performance.

What are the main risks for JACS-RI?

The main risks for Jackson Acquisition Company II include the failure to identify and acquire a suitable target company within the specified timeframe, which could lead to the liquidation of the SPAC and a return of capital to shareholders.

What are the key factors to evaluate for JACS-RI?

Jackson Acquisition Company II (JACS-RI) holds an AI score of 46/100 (low). Jackson Acquisition Company II presents an investment opportunity predicated on the successful identification and acquisition of a target company with strong growth potential. Not financial advice.

How frequently does JACS-RI data refresh on this page?

JACS-RI's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven JACS-RI's recent stock price performance?

Jackson Acquisition Company II (JACS-RI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team with expertise in the healthcare and consumer sectors. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider JACS-RI overvalued or undervalued right now?

Jackson Acquisition Company II (JACS-RI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research JACS-RI before investing?

Before investing in Jackson Acquisition Company II (JACS-RI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • The analysis is limited by the lack of historical financial data for Jackson Acquisition Company II.
Data Sources

Popular Stocks

More Stocks We Cover